These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8544674)

  • 1. Comparison of "accelerated" tissue plasminogen activator with streptokinase for treatment of suspected myocardial infarction.
    Kellett J; Clarke J
    Med Decis Making; 1995; 15(4):297-310. PubMed ID: 8544674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
    N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction.
    Kalish SC; Gurwitz JH; Krumholz HM; Avorn J
    J Gen Intern Med; 1995 Jun; 10(6):321-30. PubMed ID: 7562123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient preferences for thrombolytic therapy in acute myocardial infarction.
    Stanek EJ; Cheng JW; Peeples PJ; Simko RJ; Spinler SA
    Med Decis Making; 1997; 17(4):464-71. PubMed ID: 9343805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic therapy with streptokinase and tissue plasminogen activator in a patient with suspected acute myocardial infarction: A decision analysis.
    Hiatt MD
    Cardiology; 1999; 91(4):243-9. PubMed ID: 10545680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic therapy guided by a decision analysis model: are there potential benefits for patient management?
    Kellett J; Ryan B
    Clin Cardiol; 1998 Feb; 21(2):93-8. PubMed ID: 9491947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated tPA versus streptokinase for suspected myocardial infarction: waiting for our Mountain Dew.
    McNutt R; Evans A
    Med Decis Making; 1995; 15(4):395-6. PubMed ID: 8544683
    [No Abstract]   [Full Text] [Related]  

  • 9. Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)? An evaluation of the risks and benefits of TPA from the patient's perspective.
    Heyland DK; Gafni A; Levine MA
    J Clin Epidemiol; 2000 Sep; 53(9):888-94. PubMed ID: 11004415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs.
    Tsui W; Pierre K; Massel D
    Can J Cardiol; 2005 Apr; 21(5):423-31. PubMed ID: 15861260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.
    White HD; Barbash GI; Califf RM; Simes RJ; Granger CB; Weaver WD; Kleiman NS; Aylward PE; Gore JM; Vahanian A; Lee KL; Ross AM; Topol EJ
    Circulation; 1996 Oct; 94(8):1826-33. PubMed ID: 8873656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke complicating acute myocardial infarction. A meta-analysis of risk modification by anticoagulation and thrombolytic therapy.
    Vaitkus PT; Berlin JA; Schwartz JS; Barnathan ES
    Arch Intern Med; 1992 Oct; 152(10):2020-4. PubMed ID: 1417374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.
    Weaver WD; Simes RJ; Betriu A; Grines CL; Zijlstra F; Garcia E; Grinfeld L; Gibbons RJ; Ribeiro EE; DeWood MA; Ribichini F
    JAMA; 1997 Dec; 278(23):2093-8. PubMed ID: 9403425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential cost effectiveness of intravenous tissue plasminogen activator versus streptokinase for acute myocardial infarction.
    Goel V; Naylor CD
    Can J Cardiol; 1992; 8(1):31-8. PubMed ID: 1617509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteplase (r-TPA) vs streptokinase.
    Hunt D
    Aust N Z J Med; 1998 Aug; 28(4):514-7. PubMed ID: 9777131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the cost-effectiveness of thrombolytic therapy in acute myocardial infarct using tissue plasminogen activator or streptokinase:the Italian perspective].
    Lorenzoni R; Fattore G; Gensini G
    G Ital Cardiol; 1997 Jul; 27(7):721-6. PubMed ID: 9303862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase.
    Kent DM; Hayward RA; Griffith JL; Vijan S; Beshansky JR; Califf RM; Selker HP
    Am J Med; 2002 Aug; 113(2):104-11. PubMed ID: 12133748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombolysis in acute myocardial infarction. Streptokinase or r-TPA?].
    Silva LA; Ribeiro E; Carneiro RC; Kaissar S; Reis Filho A; Torossian SP; Tavares JR; Buffolo E; Amino JG; Duprat Filho R
    Arq Bras Cardiol; 1990 Jul; 55(1):13-7. PubMed ID: 2127353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis utilisation in acute myocardial infarction in Bahrain.
    Chawla AK; Nambiar CA; Murad AA
    Indian Heart J; 1996; 48(2):155-8. PubMed ID: 8682556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life six months after myocardial infarction treated with thrombolytic therapy. AUS-TASK Group. Australian arm of International tPA/SK Mortality Trial.
    Glasziou PP; Bromwich S; Simes RJ
    Med J Aust; 1994 Nov; 161(9):532-6. PubMed ID: 7968752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.